Cargando…

Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction

Rationale: Poor survival and engraftment are major hurdles of stem cell therapy in the treatment of myocardial infarction (MI). We sought to determine whether pre-transplantation systemic intravenous administration of human induced pluripotent stem cell (hiPSC)-derived mesenchymal stromal cells (hiP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Si-Jia, Lai, Wing-Hon, Jiang, Yu, Zhen, Zhe, Wei, Rui, Lian, Qizhou, Liao, Song-Yan, Tse, Hung-Fat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778603/ https://www.ncbi.nlm.nih.gov/pubmed/33408772 http://dx.doi.org/10.7150/thno.46119

Ejemplares similares

Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure
por: Liao, Songyan, et al.
Publicado: (2019)

Calcium Homeostasis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Lee, Yee-Ki, et al.
Publicado: (2011)

Overexpression of myocardin induces partial transdifferentiation of human‐induced pluripotent stem cell‐derived mesenchymal stem cells into cardiomyocytes
por: Zhang, Jiao, et al.
Publicado: (2014)

Induced Pluripotent Stem Cells-Derived Mesenchymal Stem Cells Attenuate Cigarette Smoke-Induced Cardiac Remodeling and Dysfunction
por: Liang, Yingmin, et al.
Publicado: (2017)

Myocardial repair of bioengineered cardiac patches with decellularized placental scaffold and human-induced pluripotent stem cells in a rat model of myocardial infarction
por: Jiang, Yu, et al.
Publicado: (2021)

Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Prevent Allergic Airway Inflammation in Mice
por: Sun, Yue-Qi, et al.
Publicado: (2012)

Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?
por: Kou, Meng, et al.
Publicado: (2022)

Mesenchymal stromal cell-derived exosomes in cardiac regeneration and repair
por: Sun, Si-Jia, et al.
Publicado: (2021)

Human induced pluripotent stem cell-derived mesenchymal stem cells prevent adriamycin nephropathy in mice
por: Wu, Hao Jia, et al.
Publicado: (2017)

Immunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications
por: Cagliani, Joaquin, et al.
Publicado: (2017)

Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy
por: Zhang, Yuelin, et al.
Publicado: (2015)

Mitochondrial transfer of mesenchymal stem cells effectively protects corneal epithelial cells from mitochondrial damage
por: Jiang, Dan, et al.
Publicado: (2016)

Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation?
por: Plock, Jan A., et al.
Publicado: (2013)

Human Ocular Epithelial Cells Endogenously Expressing SOX2 and OCT4 Yield High Efficiency of Pluripotency Reprogramming
por: Poon, Ming-Wai, et al.
Publicado: (2015)

Lenalidomide-induced focal myocarditis mimicking acute ST segment elevation myocardial infarction
por: Tse, Yiu-Hei, et al.
Publicado: (2021)

Immunomodulating Profile of Dental Mesenchymal Stromal Cells: A Comprehensive Overview
por: Paganelli, Alessia, et al.
Publicado: (2021)

Exogenous Expression of Human apoA-I Enhances Cardiac Differentiation of Pluripotent Stem Cells
por: Ng, Kwong-Man, et al.
Publicado: (2011)

Pluripotency and immunomodulatory signatures of canine induced pluripotent stem cell-derived mesenchymal stromal cells are similar to harvested mesenchymal stromal cells
por: Shahsavari, Arash, et al.
Publicado: (2021)

Recent advances in animal and human pluripotent stem cell modeling of cardiac laminopathy
por: Lee, Yee-Ki, et al.
Publicado: (2016)

Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons?
por: Liao, Song-Yan, et al.
Publicado: (2013)

Immunomodulation of Pluripotent Stem Cell-Derived Mesenchymal Stem Cells in Rotator Cuff Tears Model
por: Baek, Jieun, et al.
Publicado: (2022)

iPSC‐derived mesenchymal stem cells exert SCF‐dependent recovery of cigarette smoke‐induced apoptosis/proliferation imbalance in airway cells
por: Li, Xiang, et al.
Publicado: (2016)

Mesenchymal stem cells and immunomodulation: current status and future prospects
por: Gao, F, et al.
Publicado: (2016)

Improvement of Myocardial Function Following Catheter-Based Renal Denervation in Heart Failure
por: Liao, Song-Yan, et al.
Publicado: (2017)

Enhancing Mesenchymal Stromal Cell Immunomodulation for Treating Conditions Influenced by the Immune System
por: Guerrouahen, Bella S., et al.
Publicado: (2019)

CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects
por: Zhang, Zhao, et al.
Publicado: (2017)

Repeated intravenous administration of hiPSC-MSCs enhance the efficacy of cell-based therapy in tissue regeneration
por: Sun, Si-Jia, et al.
Publicado: (2022)

Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells
por: Lee, Yee‐Ki, et al.
Publicado: (2017)

Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation
por: Selich, Anton, et al.
Publicado: (2019)

What Makes Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Superior Immunomodulators When Compared to Bone Marrow Derived Mesenchymal Stromal Cells?
por: Bárcia, R. N., et al.
Publicado: (2015)

Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells
por: Ng, Kwong-Man, et al.
Publicado: (2014)

Mesenchymal Stem/Stromal Cells and Their Paracrine Activity—Immunomodulation Mechanisms and How to Influence the Therapeutic Potential
por: Alvites, Rui, et al.
Publicado: (2022)

The Role of COX-2 and PGE2 in the Regulation of Immunomodulation and Other Functions of Mesenchymal Stromal Cells
por: Kulesza, Agnieszka, et al.
Publicado: (2023)

Enhanced Immunomodulation in Inflammatory Environments Favors Human Cardiac Mesenchymal Stromal-Like Cells for Allogeneic Cell Therapies
por: Diedrichs, Falk, et al.
Publicado: (2019)

Induced Pluripotent Stem Cell‐Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow‐Derived Mesenchymal Stromal Cells
por: Xu, Maojia, et al.
Publicado: (2019)

Rap1 deficiency-provoked paracrine dysfunction impairs immunosuppressive potency of mesenchymal stem cells in allograft rejection of heart transplantation
por: Ding, Yue, et al.
Publicado: (2018)

Challenges in management of ST elevation myocardial infarction during COVID-19 pandemic
por: Tam, Chor-Cheung Frankie, et al.
Publicado: (2021)

Co-transplantation of Mesenchymal Stromal Cells and Induced Pluripotent Stem Cell-Derived Cardiomyocytes Improves Cardiac Function After Myocardial Damage
por: Neef, Klaus, et al.
Publicado: (2022)

Epigenetic Rejuvenation of Mesenchymal Stromal Cells Derived from Induced Pluripotent Stem Cells
por: Frobel, Joana, et al.
Publicado: (2014)

Anti-VCAM 1 Antibody-Coated Mesenchymal Stromal Cells Attenuate Experimental Colitis via Immunomodulation
por: Chen, Qianqian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qfgg8mlhk0rog3b2knb0807g7k